BAFF-R CAR T Shows Durable Responses After CD19 Therapy

Evidence Peer-reviewed publication · Discovery September 11, 2026 · Importance 5/5 · Direction Positive Summary A peer-reviewed Lancet research letter reported the completed dose-escalation cohort of PMB-CT01, an autologous BAFF-R-directed CAR-T therapy, in nine adults with relapsed or refractory B-cell non-Hodgkin lymphoma. Seven of nine…